Last updated: 5 September 2024 at 4:39pm EST

Michael J. Mano J.D. Net Worth




The estimated Net Worth of Michael Mano is at least $256 Thousand dollars as of 4 September 2024. Mr Mano owns over 3,971 units of Karyopharm Therapeutics Inc stock worth over $202,672 and over the last 3 years he sold KPTI stock worth over $53,118.

Mr D KPTI stock SEC Form 4 insiders trading

Mr has made over 4 trades of the Karyopharm Therapeutics Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently he sold 3,971 units of KPTI stock worth $2,859 on 4 September 2024.

The largest trade he's ever made was selling 20,549 units of Karyopharm Therapeutics Inc stock on 29 February 2024 worth over $24,248. On average, Mr trades about 4,411 units every 69 days since 2022. As of 4 September 2024 he still owns at least 273,881 units of Karyopharm Therapeutics Inc stock.

You can see the complete history of Mr Mano stock trades at the bottom of the page.





Mr. Michael J. Mano J.D. biography

Michael J. Mano J.D. is the Sr. VP, Gen. Counsel & Sec. at Karyopharm Therapeutics Inc.



How old is Mr D?

Mr D is 44, he's been the Sr. VP and Gen. Counsel & Sec. of Karyopharm Therapeutics Inc since . There are 22 older and 1 younger executives at Karyopharm Therapeutics Inc. The oldest executive at Karyopharm Therapeutics Inc is Garen Bohlin, 72, who is the Independent Director.

What's Mr D's mailing address?

Michael's mailing address filed with the SEC is C/O KARYOPHARM THERAPEUTICS INC., 85 WELLS AVENUE, NEWTON, MA, 02459.

Insiders trading at Karyopharm Therapeutics Inc

Over the last 11 years, insiders at Karyopharm Therapeutics Inc have traded over $149,223,596 worth of Karyopharm Therapeutics Inc stock and bought 562,763 units worth $10,312,371 . The most active insiders traders include Deepika Pakianathan, Ltd Czernik Marcin Hadjimic..., and Mikael Dolsten. On average, Karyopharm Therapeutics Inc executives and independent directors trade stock every 12 days with the average trade being worth of $26,350. The most recent stock trade was executed by Michael Mano on 4 September 2024, trading 3,971 units of KPTI stock currently worth $2,859.



What does Karyopharm Therapeutics Inc do?

karyopharm therapeutics inc. is a clinical-stage pharmaceutical company focused on discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. for more information, please visit www.karyopharm.com



What does Karyopharm Therapeutics Inc's logo look like?

Karyopharm Therapeutics Inc logo

Complete history of Mr Mano stock trades at Karyopharm Therapeutics Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
4 Sep 2024 Michael Mano
SVP, General Counsel, and Secretary
Sale 3,971 $0.72 $2,859
4 Sep 2024
273,881
29 Feb 2024 Michael Mano
SVP, General Counsel, and Secretary
Sale 20,549 $1.18 $24,248
29 Feb 2024
277,852
1 Sep 2023 Michael Mano
SVP, General Counsel, and Secretary
Sale 3,888 $1.33 $5,171
1 Sep 2023
142,234
28 Feb 2023 Michael Mano
SVP, General Counsel, and Secretary
Sale 6,878 $3.03 $20,840
28 Feb 2023
146,122


Karyopharm Therapeutics Inc executives and stock owners

Karyopharm Therapeutics Inc executives and other stock owners filed with the SEC include: